Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Sayler

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Clinical Psychopharmacology|January 1, 1993
Severity of depression and response to fluoxetineA C Pande, M E Sayler
International Clinical Psychopharmacology|January 1, 1993
Adverse events and treatment discontinuations in fluoxetine clinical trialsA C Pande, M E Sayler
Depression and Anxiety|January 1, 1996
Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetineG D Tollefson, M E Sayler
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trialC M Beasley, M E Sayler, J H Potvin
Journal of Clinical Psychopharmacology|June 1, 1991
High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depressionC M Beasley, M E Sayler, J C Bosomworth, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 1, 1994
Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial dataM E Sayler, D J Goldstein, P J Roback, et al.
The Journal of Clinical Psychiatry|February 1, 1994
Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious featuresG D Tollefson, S L Holman, M E Sayler, et al.
Journal of Clinical Psychopharmacology|October 11, 1992
Fluoxetine: activating and sedating effects at multiple fixed dosesC M Beasley, M E Sayler, A M Weiss, et al.
Journal of Clinical Psychopharmacology|April 22, 1999
Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxietyW T Smith, P D Londborg, S L Blomgren, et al.
The Journal of Clinical Psychiatry|July 1, 1991
Fluoxetine versus trazodone: efficacy and activating-sedating effectsC M Beasley, B E Dornseif, J A Pultz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Clinical Psychopharmacology|January 1, 1993
Severity of depression and response to fluoxetineA C Pande, M E Sayler
International Clinical Psychopharmacology|January 1, 1993
Adverse events and treatment discontinuations in fluoxetine clinical trialsA C Pande, M E Sayler
Depression and Anxiety|January 1, 1996
Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetineG D Tollefson, M E Sayler
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trialC M Beasley, M E Sayler, J H Potvin
Journal of Clinical Psychopharmacology|June 1, 1991
High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depressionC M Beasley, M E Sayler, J C Bosomworth, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 1, 1994
Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial dataM E Sayler, D J Goldstein, P J Roback, et al.
The Journal of Clinical Psychiatry|February 1, 1994
Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious featuresG D Tollefson, S L Holman, M E Sayler, et al.
Journal of Clinical Psychopharmacology|October 11, 1992
Fluoxetine: activating and sedating effects at multiple fixed dosesC M Beasley, M E Sayler, A M Weiss, et al.
Journal of Clinical Psychopharmacology|April 22, 1999
Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxietyW T Smith, P D Londborg, S L Blomgren, et al.
The Journal of Clinical Psychiatry|July 1, 1991
Fluoxetine versus trazodone: efficacy and activating-sedating effectsC M Beasley, B E Dornseif, J A Pultz, et al.
Pageof 2